Zimmer Biomet (ZBH) PT Lowered to $95 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Patrick Wood lowered the price target on Zimmer Biomet (NYSE: ZBH) to $95.00 (from $115.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
